Receptor-mediated modulation of avian caecal muscle contraction by melatonin: role of tyrosine protein kinase

J Pineal Res. 2002 Apr;32(3):199-208. doi: 10.1034/j.1600-079x.2002.1o857.x.

Abstract

Abstract: Melatonin receptors in the quail caecum were studied by 2[125I]iodomelatonin binding assay and the involvement of tyrosine protein kinase in the melatonin-induced contraction was explored. The binding of 2[125I]iodomelatonin in the quail caecum membrane preparations was saturable, reversible and of high affinity with an equilibrium dissociation constant (Kd) of 24.6 +/- 1.1 pm (n = 7) and a maximum number of binding sites (Bmax) of 1.95 +/- 0.09 fmol (mg/protein) (n = 7). The relative order of potency of indoles in competing for 2[125I]iodomelatonin binding was: 2-iodomelatonin > melatonin > 2-phenylmelatonin > 6-chloromelatonin > 6-hydroxymelatonin > N-acetylserotonin, indicating that ML(1) receptors are involved. The binding was inhibited by Mel1b melatonin receptor antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT) as well as by non-hydrolyzable analogs of GTP like GTPgammaS and Gpp(NH)p but not by adenosine nucleotides. The latter suggests that the action of melatonin on the caecum is G-protein linked. Cumulative addition of melatonin (1-300 nM) potentiated both the amplitude and frequency of spontaneous contractions in the quail caecum. The potentiation of rhythmic contractions was blocked by both luzindole and 4-P-PDOT. Antagonists of tyrosine kinase, genistein(2 microM) and erbstatin(4 microM) suppressed the modulation of spontaneous contractions by melatonin, but not inhibitors of protein kinase C (PKC) or protein kinase A (PKA). Melatonin-induced increment in spontaneous contraction was blocked by nifedipine (0.4 nM). Thus, we suggest that melatonin potentiates spontaneous contraction in the quail caecum via interacting with G-protein-coupled Mel(1b) receptor which may activate L-type Ca2+ channels by mobilizing tyrosine kinases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology
  • Animals
  • Apamin / pharmacology
  • Binding, Competitive
  • Cecum / drug effects*
  • Cecum / metabolism
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Guanosine 5'-O-(3-Thiotriphosphate) / metabolism
  • Guanosine 5'-O-(3-Thiotriphosphate) / pharmacology
  • Guanosine Triphosphate / metabolism
  • Guanosine Triphosphate / pharmacology
  • Indoles / metabolism
  • Melatonin / analogs & derivatives*
  • Melatonin / metabolism*
  • Melatonin / pharmacology
  • Muscle Contraction / drug effects
  • Muscle Contraction / physiology*
  • Muscle, Smooth / drug effects
  • Muscle, Smooth / metabolism
  • Naphthalenes / pharmacology
  • Potassium Channels / drug effects
  • Potassium Channels / metabolism
  • Protein-Tyrosine Kinases / metabolism*
  • Quail
  • Receptors, Cell Surface / antagonists & inhibitors
  • Receptors, Cell Surface / drug effects
  • Receptors, Cell Surface / metabolism*
  • Receptors, Cytoplasmic and Nuclear / antagonists & inhibitors
  • Receptors, Cytoplasmic and Nuclear / drug effects
  • Receptors, Cytoplasmic and Nuclear / metabolism*
  • Receptors, Melatonin
  • Tetrahydronaphthalenes / pharmacology
  • Tryptamines / pharmacology

Substances

  • 4-phenyl-2-propionamidotetraline
  • Enzyme Inhibitors
  • Indoles
  • Naphthalenes
  • Potassium Channels
  • Receptors, Cell Surface
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Melatonin
  • Tetrahydronaphthalenes
  • Tryptamines
  • luzindole
  • Apamin
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Guanosine Triphosphate
  • 2-iodomelatonin
  • Protein-Tyrosine Kinases
  • calphostin C
  • Melatonin